Union Therapeutics Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$5.4M
- Investors
-
6
Union Therapeutics General Information
Description
Operator of an oral small-molecule pharmaceutical platform intended to develop and commercialize treatments for inflammatory and immunologic diseases. The company offers oral therapies targeting conditions such as psoriasis, atopic dermatitis, hidradenitis suppurativa, and rare immunologic diseases, enabling patients and healthcare providers to access treatments for diseases with significant unmet medical needs.
Contact Information
Website
www.uniontherapeutics.comCorporate Office
- Tuborg Havnevej 18
- 2900 Hellerup
- Denmark
Corporate Office
- Tuborg Havnevej 18
- 2900 Hellerup
- Denmark
Union Therapeutics Timeline
Union Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Later Stage VC | 19-Jun-2026 | $5.4M | Completed | Clinical Trials - Phase 2 | ||
| 12. Later Stage VC | 13-Jul-2023 | Completed | Clinical Trials - Phase 2 | |||
| 11. Later Stage VC | 16-Jul-2021 | Completed | Clinical Trials - Phase 2 | |||
| 10. Later Stage VC (Series A) | 09-Feb-2021 | Completed | Clinical Trials - Phase 2 | |||
| 9. Later Stage VC | 23-Jun-2020 | Completed | Clinical Trials - Phase 2 | |||
| 8. Grant | 01-Mar-2020 | Completed | Clinical Trials - Phase 2 | |||
| 7. Later Stage VC | 31-Dec-2017 | Completed | Clinical Trials - Phase 2 | |||
| 6. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 | ||||
| 5. Debt - General | 26-Oct-2017 | $23.6M | $31M | Completed | Clinical Trials - Phase 1 | |
| 4. Grant | 01-Aug-2017 | $4M | $7.43M | Completed | Clinical Trials - Phase 1 |
Union Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | 7,922 | $293.79 | $293.79 | 1x | $293.79 | 1.01% | ||
| Ordinary Shares | 8,000 | $659.44 | $659.44 | 1x | $659.44 | 1.02% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Union Therapeutics Comparisons
Industry
Financing
Details
Union Therapeutics Competitors (12)
One of Union Therapeutics’s 12 competitors is Incyte, a Formerly VC-backed company based in Wilmington, DE.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Incyte | Formerly VC-backed | Wilmington, DE | ||||
| Apogee Therapeutics | Formerly VC-backed | Waltham, MA | ||||
| LEO Pharma | Private Equity-Backed | Ballerup, Denmark | ||||
| RAPT Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Kymera Therapeutics | Formerly VC-backed | Watertown, MA |
Union Therapeutics Signals
Union Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| T&W Medical | Family Office | Minority | ||
| European Investment Bank | Investment Bank | Minority | ||
| The Innovation Fund | Venture Capital | Minority | ||
| Horizon 2020 | Government | |||
| Technical University of Denmark | University |
Union Therapeutics Investments (1)
Union Therapeutics’s most recent deal was a Corporate Asset Purchase with LEO Pharma (Rights of PDE4 Inhibitor Series). The deal was made on 23-Jul-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| LEO Pharma (Rights of PDE4 Inhibitor Series) | 23-Jul-2020 | Corporate Asset Purchase | Buildings and Property |
Union Therapeutics FAQs
-
When was Union Therapeutics founded?
Union Therapeutics was founded in 2011.
-
Where is Union Therapeutics headquartered?
Union Therapeutics is headquartered in Hellerup, Denmark.
-
What is the size of Union Therapeutics?
Union Therapeutics has 6 total employees.
-
What industry is Union Therapeutics in?
Union Therapeutics’s primary industry is Drug Discovery.
-
Is Union Therapeutics a private or public company?
Union Therapeutics is a Private company.
-
What is the current valuation of Union Therapeutics?
The current valuation of Union Therapeutics is .
-
What is Union Therapeutics’s current revenue?
The current revenue for Union Therapeutics is .
-
How much funding has Union Therapeutics raised over time?
Union Therapeutics has raised $114M.
-
Who are Union Therapeutics’s investors?
T&W Medical, European Investment Bank, The Innovation Fund, Horizon 2020, and Technical University of Denmark are 5 of 6 investors who have invested in Union Therapeutics.
-
Who are Union Therapeutics’s competitors?
Incyte, Apogee Therapeutics, LEO Pharma, RAPT Therapeutics, and Kymera Therapeutics are some of the 12 competitors of Union Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process